Table 1

Effects of the methanol extract from C. zeylanicum on lipid profile in L-NAME hypertensive rats
Treatment Triglycerides (mg/dl) Total cholesterol (mg/dl) HDL-cholesterol (mg/dl) LDL-cholesterol (mg/dl) Atherogenic index
Control 53.48 ± 3.36 50.63 ± 2.07 48.76 ± 3.13 5.51 ± 3.68 1.06 ± 0.31
L-NAME 81.10 ± 3.80β 83.13 ± 4.02γ 17.57 ± 2.82β 38.52 ± 4.29β 5.35 ± 0.48γ
L-N + Capto 45.74 ± 3.36** 48.12 ± 2.09*** 40.40 ± 3.32** 4.50 ± 3.96*** 1.50 ± 0.70***
L-N + MECZ 50.16 ± 3.33* 56.46 ± 5.29*** 42.26 ± 3.83** 9.50 ± 3.08*** 1.41 ± 0.18***

n = 5; βp < 0.01 and γp < 0.001 significantly different compared to the control; *p < 0.05, **p < 0.01 and ***p < 0.001 significantly different compared to L-NAME. L-NAME group received only L-NAME 40 mg/kg/day. L-N + Capto received L-NAME plus captopril (20 mg/kg/day) while L-N + MECZ received L-NAME plus extract (300 mg/kg/day).

Nyadjeu et al.

Nyadjeu et al. BMC Complementary and Alternative Medicine 2013 13:27   doi:10.1186/1472-6882-13-27

Open Data